Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treat Stroke to Target (TST)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Assistance Publique - Hôpitaux de Paris
Sponsor:
Collaborators:
Pfizer
AstraZeneca
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01252875
First received: December 2, 2010
Last updated: May 17, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)